APOE, apolipoprotein E, 348

N. diseases: 1049; N. variants: 62
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE In a randomly sampled cross-sectional study of 985 South Asian, Chinese, and European Canadians, three common isoforms of ApoE (E2, E3 and E4), plasma lipid concentrations and atherosclerosis of the carotid artery were measured. 18656198 2009
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Among 1677 nondemented ARIC (Atherosclerosis Risk in Communities) participants (mean age=76±5 years; 40% men; 26% black) with 3-Tesla MRI scans at the fifth examination (2011-2013), we fit multinomial logistic regression models to quantify relationships of brain volumes (Alzheimer disease signature regions, total gray matter, frontal gray matter, and white matter hyperintensity volumes), infarct frequencies (lacunar, nonlacunar, and total), and apolipoprotein E (number of ε4 alleles) with CMB location (none, deep/mixed, or strictly lobar CMBs). 29018129 2017
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. 7762561 1995
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function. 15142050 2004
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE In this study, we evaluated the effects of complete IL-25 deficiency or of a temporal IL-25 blockade on atherosclerosis development in apolipoprotein E-deficient (<i>Apoe</i><sup>-/-</sup>) mice. 29572351 2018
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE We recently described that apolipoprotein E (ApoE) deficient mice with a mutation in the fibrillin-1 (Fbn1) gene (ApoE<sup>-/-</sup>Fbn1<sup>C1039G+/-</sup>) develop accelerated atherosclerosis, plaque rupture, myocardial infarction, cerebral hypoxia and sudden death. 31085310 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Clinical and autoptical studies have suggested a predisposing role of the allele E4 of apolipoprotein E (apoE) in the development of atherosclerosis and cardiovascular disease. 9012642 1997
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE The molecular polymorphism displayed by apolipoprotein E (apoE, protein; APOE, gene) has been listed as a risk factor for susceptibility to various disorders, such as those associated with lipid metabolism and arteriosclerosis. 14763609 2003
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Beyond the known influence of ApoE polymorphisms on serum lipid profile, the pathogenesis of atherosclerosis, and the development of neurodegenerative disorders, ApoE also has a major role in the pathogenesis and progression of a variety of renal diseases, as well as in the atherosclerotic complications associated with them. 14750087 2004
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE On the other hand, apolipoprotein E3/2 heterozygosity may have a protective effect on the development of early atherosclerosis. 6882285 1983
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE The objective of this study was to investigate the influence of the APOE promoter (-491 A/T, -427 T/C and -219 G/T) and coding region (APOE epsilon2/epsilon3/epsilon4) polymorphisms in atherosclerosis disease by association and linkage disequilibrium analyses. 18219091 2008
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE As atherosclerosis is provoked by both inflammation and hyperlipidemia, we aimed to determine the effect of inulin supplementation on atherosclerosis development in hypercholesterolemic <i>APOE*3-Leiden</i> (<i>E3L</i>) mice. 29401645 2018
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE These findings support extension of the importance of the apoE4 allele beyond atherosclerosis and Alzheimer's disease to calcific AS. 14530190 2003
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. 12774036 2003
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Risk for arteriosclerosis is modulated by the apolipoprotein E (apoE) allele. 11096027 2000
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Since nuclear factor-κB (NF-κB) is a central regulator of inflammatory processes, we hypothesized that chronically enhanced hepatic NF-κB activation, through hepatocyte-specific expression of IκB kinase-β (IKKβ) (LIKK), will aggravate atherosclerosis development in APOE*3-Leiden (E3L) mice. 21798539 2012
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE We studied the association of classic genotypes of the apoE gene with clinical and biochemical risk factors for atherosclerosis in a segment of the very-old Brazilian individuals, with emphasis on the lipemic profile. 24530308 2014
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway. 31645538 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Here, we evaluated the contribution of CD39 to atherogenesis in the apolipoprotein E-deficient (ApoE-deficient) mouse model of atherosclerosis. 26121751 2015
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE A previous study showed that the omega-6 fatty acid, dihomo-γ-linolenic acid (DGLA), attenuated atherosclerosis in the apolipoprotein E deficient mouse model system. 31202985 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE It is yet unclear whether the apolipoprotein E polymorphism (APOE) is related to atherosclerosis in the carotid arteries. 11546879 2001
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE The inheritance of specific apolipoprotein E allelles has been linked to atherosclerosis, Alzheimer disease, and, most recently, to the incidence of age-related macular degeneration. 11384575 2001
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE Apolipoprotein E gene polymorphisms and retinal vascular signs: the atherosclerosis risk in communities (ARIC) study. 17562993 2007
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE To study the role of endothelial HIF-1α in atherosclerosis, deletion of the Hif1a gene was induced in ECs from apolipoprotein E knockout mice (EC-Hif1a(-/-)) by Tamoxifen injection. 26483345 2015
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.400 GeneticVariation disease BEFREE (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B. 29593532 2018